The Qui Tam Team Blog Join In the Fight Against Fraud

26May/100

A Fraud By Any Other Name Would Be As… Expensive

This post was written by Josh

The False Claims Act provides for treble damages and a penalty between $5,500 and $11,000 for anyone who submits a false claim to the United States. With treble damages and penalties, committing fraud against the government can become a very expensive proposition. It's hard to see how high-level executives at the companies being sued in qui tam suits could think that fraud is a good way to do business, but this seems to be the logic that was followed in several cases.

In looking at the top 27 FCA cases, 93% of them have to do with some type of healthcare fraud. In fact, among the top 5 FCA cases, each one is related in some way to the healthcare industry.

At the top of the list is drug-making mastodon Pfizer. In the fall of 2009, Pfizer agreed to pay $2.3 billion to settle claims, including claims brought under the FCA. $1.3 billion of the settlement constituted criminal penalties. This penalty sounds like it would be the final straw for Pfizer, but when you consider Pfizer's 3rd quarter 2009 profit alone was $2.88 billion, you have to wonder whether even an enormous fine like this is enough to deter a drug company from potentially engaging in fraud.  Pfizer was sued for allegedly marketing certain popular drugs like Bextra and Lipitor for unapproved uses. The company made huge profits off of these drugs, and legal experts are not convinced that fines will prevent drug makers from going down the same road in the future.

The FCA keeps drug companies on their toes, but it remains to be seen whether fraud will be completely eliminated.  Our society does love its drugs--prescription drugs are so ubiquitous that they are even showing up in trace amounts in public drinking water supplies--and as long as profits outweigh fines, the temptation to engage in fraud to increase those profits will probably endure.

This article is brought to you by The Qui Tam Team, the epicenter for whistleblowers and people interested in the False Claims Act, Qui Tam Provisions, and Medicare and Medicaid fraud. To discuss a potential case, please call Eric Young at 1 (800) 590-4116.

6May/100

Whistle Blown on KBR Once Again

This post was written by Josh

The army just can't seem to break it off with military contractor KBR. They're like that couple everyone wants to break up, but they stay together--usually with one party taking advantage of the other. We've recently blogged about KBR's ongoing legal troubles, but here is just one more volume for a shelf sagging under the weight.

Even though the DOJ has just joined a whistleblower lawsuit against KBR, the Army has announced a $568 million no-bid contract with the company through 2011 for military support services in Iraq.

KBR allegedly accepted meals, sports tickets, and golf outings from two freight forwarding companies.

KBR denies the allegations, of course, and in a statement said that "Gifts of dinners, baseball tickets and other similar items would violate KBR policies." This is sort of like saying, "It would just be so awful if some (hypothetical, of course) company bribed officials. Nothing specific, other than dinners and baseball tickets...er..." KBR went on to say that maybe, possibly, if this hypothetical naughty company did give any gifts, they would have been less than $20,000. No big deal, right?

The problem is that this kind of behavior ends up costing taxpayers money in the end. Although the government hasn't definitively stated whether the kickbacks cost taxpayers money yet, there is a strong possibility that KBR passed up companies offering lower costs for those that bought the best dinners and seats for games. Choosing a supplier on the basis of the gifts they provide shifts a government contractor's priorities away from where they belong (providing the best value to the taxpayer) and warps the "bidding" process into one in which the contractor puts its own interests first.  Fortunately, there are whistleblowers out there to help keep contractors like KBR in check.

This article was sponsored by The Qui Tam Team, the epicenter for whistleblowers and people interested in the False Claims Act, Qui Tam Provisions, and Medicare and Medicaid fraud. To discuss a potential case, please call Eric Young at 1 (800) 590-4116.

4May/100

False Patent Claims: An Interesting Qui Tam Wrinkle

This post was written by Josh

A new frontier appears to be opening up for qui tam: suits for filing false patent marks.

The relevant section of the law pertaining to patents (35 U.S.C 292) states:

(a) Whoever, without the consent of the patentee, marks upon, or affixes to, or uses in advertising in connection with anything made, used, offered for sale, or sold by such person within the United States, or imported by the person into the United States, the name or any imitation of the name of the patentee, the patent number, or the words "patent," "patentee," or the like, with the intent of counterfeiting or imitating the mark of the patentee, or of deceiving the public and inducing them to believe that the thing was made, offered for sale, sold, or imported into the United States by or with the consent of the patentee; or Whoever marks upon, or affixes to, or uses in advertising in connection with any unpatented article the word "patent" or any word or number importing the same is patented, for the purpose of deceiving the public; or Whoever marks upon, or affixes to, or uses in advertising in connection with any article the words "patent applied for," "patent pending," or any word importing that an application for patent has been made, when no application for patent has been made, or if made, is not pending, for the purpose of deceiving the public - Shall be fined not more than $500 for every such offense.

(b) Any person may sue for the penalty, in which event one-half shall go to the person suing and the other to the use of the United States.

Note that the law provides for qui tam suits in subsection (b), with a hefty 50% of the recovery going to the relator.

False marking "includes marking unpatented product as “patented” or marking a product as 'patent pending' when no patent is pending." The tricky issues arise when manufacturers lose track of patents or continue to manufacture products bearing a patent number that has long expired.

In the now-famous/infamous case Pequignot v. Solo Cup Co., the plaintiff, Matthew Pequignot, alleged that Solo Cup falsely marked certain products with expired patent numbers and improperly marked others with conditional patent markings. Notably, Pequignot is a patent attorney, so presumably knows more about this area of the law than the average bear. Also, the case involves about 21 billion lids, each of which could potentially constitute an "offense" under the aforementioned law and carrying a $500 fine.

Solo tried to get the case dismissed on several grounds, including an argument that Pequignot lacked standing as a qui tam relator. The federal district court, however, wasn't buying, and denied Solo's Motion to Dismiss. In regard to Solo's arguments that suits like Pequignot's were not what Congress had in mind when it made qui tam suits available in false marking suits, the court noted that Congress had the opportunity to change the law, but may have decided that the benefits of allowing citizens to blow the whistle on falsely marked products outweighed the burdens.

It will be very interesting to see how the Pequignot case turns out. Given that we as a society consume so many patented products, the stakes are extremely high.

This article was sponsored by The Qui Tam Team, the epicenter for whistleblowers and people interested in the False Claims Act, Qui Tam Provisions, and Medicare and Medicaid fraud. To discuss a potential case, please call Eric Young at 1 (800) 590-4116.